| Summary Of Effect Of Restatement On Financial Statement |
|
|
|
|
|
|
|
|
|
|
|
|
As Previously |
|
|
|
|
|
|
|
|
Reported |
|
Adjustment |
|
As restated |
Balance Sheet at November 27, 2020 |
|
|
|
|
|
|
|
|
|
Warrant liability |
|
$ |
— |
|
$ |
36,549,753 |
|
$ |
36,549,753 |
Total liabilities |
|
|
5,680,163 |
|
|
36,549,753 |
|
|
42,229,916 |
Class A ordinary shares subject to possible redemption |
|
|
156,885,627 |
|
|
(36,549,754) |
|
|
120,335,873 |
Class A ordinary shares |
|
|
92 |
|
|
360 |
|
|
442 |
Additional paid-in capital |
|
|
5,007,093 |
|
|
12,232,284 |
|
|
17,239,377 |
Accumulated deficit |
|
|
(7,611) |
|
|
(12,232,643) |
|
|
(12,240,254) |
Total Shareholders’ Equity |
|
|
5,000,005 |
|
|
1 |
|
|
5,000,006 |
Balance Sheet at December 31, 2020 |
|
|
|
|
|
|
|
|
|
Warrant liability |
|
$ |
— |
|
$ |
36,549,753 |
|
$ |
36,549,753 |
Total liabilities |
|
|
5,859,668 |
|
|
36,549,753 |
|
|
42,409,421 |
Class A ordinary shares subject to possible redemption |
|
|
156,864,332 |
|
|
(36,549,754) |
|
|
120,314,578 |
Class A ordinary shares |
|
|
93 |
|
|
360 |
|
|
453 |
Additional paid-in capital |
|
|
5,028,387 |
|
|
12,232,284 |
|
|
17,260,671 |
Accumulated deficit |
|
|
(28,906) |
|
|
(12,232,643) |
|
|
(12,261,549) |
Total Shareholders’ Equity |
|
$ |
5,000,005 |
|
$ |
1 |
|
$ |
5,000,006 |
Statement of Operations for the period from July 29, 2020 (inception) through December 31, 2020 |
|
|
|
|
|
|
|
|
|
Excess of fair value of Private Placement Warrants |
|
|
— |
|
|
(11,211,642) |
|
|
(11,211,642) |
Transaction costs |
|
$ |
— |
|
$ |
(1,021,001) |
|
$ |
(1,021,001) |
Total other income/(expense) |
|
|
10,751 |
|
|
(12,232,643) |
|
|
(12,221,892) |
Net Loss |
|
|
(28,906) |
|
|
(12,232,643) |
|
|
(12,261,549) |
Basic and diluted net loss per share, Class B Ordinary shares |
|
$ |
0.00 |
|
$ |
(3.20) |
|
|
(3.20) |
Statement of Cash Flows for the period from July 29, 2020 (inception) through December 31, 2020 |
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities: |
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(28,906) |
|
$ |
(12,232,643) |
|
$ |
(12,261,549) |
Excess of fair value of Private Placement Warrants |
|
|
— |
|
|
11,211,642 |
|
|
11,211,642 |
Transaction costs |
|
|
|
|
|
1,021,001 |
|
|
1,021,001 |
Net cash used in operating activities |
|
|
(97,168) |
|
|
— |
|
|
(97,168) |
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
|
|
|
Class A ordinary shares subject to possible redemption |
|
|
156,864,332 |
|
|
(36,549,754) |
|
|
120,314,578 |
Initial classification of warrant liability |
|
|
— |
|
|
36,549,753 |
|
|
36,549,753 |
|